Prime-Boost: mRNA Tumor Vaccines in Combination with Oncolytic Virotherapy for Durable Anti-Tumor Immunity

被引：0
|
作者：
Jia, William
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2025年 / 13卷 / 02期
关键词：
D O I：
10.1158/2326-6074.IO2025-B016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B016
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Armed oncolytic viruses: A kick-start for anti-tumor immunity
    de Graaf, J. F.
    de Vor, L.
    Fouchier, R. A. M.
    van den Hoogen, B. G.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2018, 41 : 28 - 39
  • [22] Boosting CAR T cells with anti-tumor mRNA vaccines
    Chehrazi-Raffle, Alex
    Budde, Lihua E.
    Pal, Sumanta K.
    NATURE MEDICINE, 2023, 29 (11) : 2711 - 2712
  • [23] Boosting CAR T cells with anti-tumor mRNA vaccines
    Alex Chehrazi-Raffle
    Lihua E. Budde
    Sumanta K. Pal
    Nature Medicine, 2023, 29 : 2711 - 2712
  • [24] Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity
    Judit Svensson-Arvelund
    Sara Cuadrado-Castano
    Gvantsa Pantsulaia
    Kristy Kim
    Mark Aleynick
    Linda Hammerich
    Ranjan Upadhyay
    Michael Yellin
    Henry Marsh
    Daniel Oreper
    Suchit Jhunjhunwala
    Christine Moussion
    Miriam Merad
    Brian D. Brown
    Adolfo García-Sastre
    Joshua D. Brody
    Nature Communications, 13
  • [25] Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity
    Svensson-Arvelund, Judit
    Cuadrado-Castano, Sara
    Pantsulaia, Gvantsa
    Kim, Kristy
    Aleynick, Mark
    Hammerich, Linda
    Upadhyay, Ranjan
    Yellin, Michael
    Marsh, Henry
    Oreper, Daniel
    Jhunjhunwala, Suchit
    Moussion, Christine
    Merad, Miriam
    Brown, Brian D.
    Garcia-Sastre, Adolfo
    Brody, Joshua D.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [26] Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation
    Kim, So Young
    Kang, Dongxu
    Choi, Hye Jin
    Joo, Yeonsoo
    Kim, Joo-Hang
    Song, Jae J.
    ONCOTARGET, 2017, 8 (09) : 15858 - 15877
  • [27] Nanotechnology based therapeutic modality to boost anti-tumor immunity and collapse tumor defense
    Hu, Xiaomeng
    Wu, Tingting
    Bao, Yuling
    Zhang, Zhiping
    JOURNAL OF CONTROLLED RELEASE, 2017, 256 : 26 - 45
  • [28] Induction of anti-tumor immunity by anti-tumor monoclonal antibodies
    Dhodapkar, Madhav V.
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 635 - 635
  • [29] Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression
    Ramirez-Valdez, Ramiro A.
    Baharom, Faezzah
    Khalilnezhad, Ahad
    Fussell, Sloane C.
    Hermans, Dalton J.
    Schrager, Alexander M.
    Tobin, Kennedy K. S.
    Lynn, Geoffrey M.
    Khalilnezhad, Shabnam
    Ginhoux, Florent
    Van den Eynde, Benoit J.
    Leung, Carol Sze Ki
    Ishizuka, Andrew S.
    Seder, Robert A.
    CELL REPORTS, 2023, 42 (06):
  • [30] Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy
    Ilett, E.
    Kottke, T.
    Thompson, J.
    Rajani, K.
    Zaidi, S.
    Evgin, L.
    Coffey, M.
    Ralph, C.
    Diaz, R.
    Pandha, H.
    Harrington, K.
    Selby, P.
    Bram, R.
    Melcher, A.
    Vile, R.
    GENE THERAPY, 2017, 24 (01) : 21 - 30
12345